Article
BRCA1/2 mutation carriers are potentially at higher cardiovascular risk.
Critical reviews in oncology/hematology - 1 Aug 2014
Arts-de Jong M, Maas A H E M, Massuger L F, Hoogerbrugge N, de Hullu J A
Abstract excerpt
BRCA1/2 mutation carriers have an elevated risk of developing breast and ovarian cancer at a relatively young age. Risk-reducing salpingo-oophorectomy is an established strategy to tremendously reduce the risk of ovarian cancer. It is recommended to perform this surgery at age 35-40 years (BRCA1) and at age 40-45 years (BRCA2) resulting in an early and abrupt menopause. BRCA1/2 mutation carriers are potentially...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
